English | Español
Patient Daily | Feb 4, 2026

Lilly partners with Seamless Therapeutics on $1.12B+ gene editing deal for hearing loss
Patient Daily | Feb 4, 2026

Cellares raises $257M for expansion of automated cell therapy manufacturing
Patient Daily | Feb 4, 2026

Roche reports positive results in obesity drug trial; Moderna halts vaccine studies
Patient Daily | Feb 4, 2026

FDA holds up REGENXBIO's Hunter syndrome program; Denali may move ahead
Patient Daily | Feb 4, 2026

Cardiff Oncology faces executive departures and mixed phase II trial results
Patient Daily | Feb 4, 2026

FDA approves new frontline use for J&J's Darzalex Faspro in multiple myeloma
Patient Daily | Feb 4, 2026

Baylor College team develops method for sustained laboratory growth of human norovirus
Patient Daily | Feb 4, 2026

Study finds Americans expect families—especially spouses—to lead eldercare responsibilities

Trending
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'